Vertex Pharmaceuticals Inc / Ma

VRTXNasdaqCIK 875320HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Reports and events: 289 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Vertex Pharmaceuticals Inc / Ma, Reports and events
Filed	Form	What it is	Accession number
2016-10-2520:11 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000875320-16-000104
2016-10-1712:39 ET	8-K	1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 2.04 Item not in the standard list	0000875320-16-000098
2016-10-1412:04 ET	8-K	1.01 Entry into a material agreement; 8.01 Other events	0000875320-16-000096
2016-08-0120:51 ET	10-Q	Quarterly reportPeriod 2016-06-30	0000875320-16-000091
2016-07-2720:16 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000875320-16-000088
2016-06-1520:34 ET	8-K	5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results	0000875320-16-000083
2016-05-0321:03 ET	10-Q	Quarterly reportPeriod 2016-03-31	0000875320-16-000078
2016-04-2913:27 ET	DEF 14A	Proxy statementPeriod 2015-12-31	0000875320-16-000074
2016-04-2720:13 ET	8-K	2.02 Results of operations; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits	0000875320-16-000070
2016-02-1621:23 ET	10-K	Annual reportPeriod 2015-12-31	0000875320-16-000067
2016-01-2721:27 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000875320-16-000063
2016-01-1112:14 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000875320-16-000061
2015-12-0821:14 ET	8-K	1.01 Entry into a material agreement; 2.03 New direct financial obligation	0000875320-15-000058
2015-10-3020:23 ET	10-Q	Quarterly reportPeriod 2015-09-30	0000875320-15-000056
2015-10-2820:33 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000875320-15-000053
2015-10-2720:33 ET	8-K	1.01 Entry into a material agreement	0000875320-15-000051
2015-08-0420:16 ET	10-Q	Quarterly reportPeriod 2015-06-30	0000875320-15-000047
2015-07-2920:26 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000875320-15-000042
2015-07-0218:40 ET	8-K	8.01 Other events	0000875320-15-000040
2015-06-1220:23 ET	8-K	5.02 Departure or appointment of officers or directors	0000875320-15-000037
2015-06-0912:58 ET	8-K	1.01 Entry into a material agreement	0000875320-15-000035
2015-06-0415:43 ET	8-K	1.01 Entry into a material agreement; 5.07 Shareholder vote results	0000875320-15-000033
2015-05-0420:29 ET	10-Q	Quarterly reportPeriod 2015-03-31	0000875320-15-000029
2015-04-3015:18 ET	DEF 14A	Proxy statementPeriod 2014-12-31	0000875320-15-000025
2015-04-2920:10 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000875320-15-000023
2015-02-1321:23 ET	10-K	Annual reportPeriod 2014-12-31	0000875320-15-000012
2015-01-2821:43 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000875320-15-000009
2015-01-2021:58 ET	8-K	5.02 Departure or appointment of officers or directors	0000875320-15-000006
2015-01-1212:11 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000875320-15-000002
2014-12-1521:52 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0000875320-14-000066
2014-11-0621:02 ET	10-Q	Quarterly reportPeriod 2014-09-30	0000875320-14-000063
2014-10-2820:29 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000875320-14-000061
2014-07-3121:08 ET	10-Q	Quarterly reportPeriod 2014-06-30	0000875320-14-000058
2014-07-2920:22 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000875320-14-000053
2014-07-1123:11 ET	8-K	5.02 Departure or appointment of officers or directors	0000875320-14-000042
2014-07-0920:48 ET	8-K	1.01 Entry into a material agreement; 2.03 New direct financial obligation	0000875320-14-000040
2014-06-2520:16 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0000875320-14-000038
2014-06-1921:17 ET	8-K	1.01 Entry into a material agreement	0000875320-14-000030
2014-05-0720:21 ET	8-K	1.01 Entry into a material agreement; 5.07 Shareholder vote results	0000875320-14-000028
2014-05-0520:07 ET	10-Q	Quarterly reportPeriod 2014-03-31	0000875320-14-000026
2014-05-0120:12 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000875320-14-000024
2014-03-2820:05 ET	DEF 14A	Proxy statementPeriod 2014-05-07	0000875320-14-000019
2014-02-1121:38 ET	10-K	Annual reportPeriod 2013-12-31	0000875320-14-000015
2014-02-0521:04 ET	8-K	5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits	0000875320-14-000012
2014-01-3121:33 ET	8-K/A	2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits	0000875320-14-000010
2014-01-2921:38 ET	8-K	2.01 Completion of an acquisition or disposition; 2.02 Results of operations; 2.06 Material impairments; 9.01 Financial statements and exhibits	0000875320-14-000007
2014-01-1321:47 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000875320-14-000005
2013-11-2221:19 ET	8-K	1.01 Entry into a material agreement	0000875320-13-000047
2013-11-0721:22 ET	10-Q	Quarterly reportPeriod 2013-09-30	0000875320-13-000045
2013-10-2912:18 ET	8-K	2.02 Results of operations; 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits	0000875320-13-000042

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 12:56 ET. Listed shows no prices and gives no investment advice.